IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $43,493,000 | +125.2% | 511,500 | -6.1% | 11.81% | +111.6% |
| Q2 2020 | $19,315,000 | +508.5% | 545,000 | +263.3% | 5.58% | +610.1% |
| Q4 2019 | $3,174,000 | +1.7% | 150,000 | -33.3% | 0.79% | -29.2% |
| Q2 2019 | $3,121,000 | -67.5% | 225,000 | -55.0% | 1.11% | -75.7% |
| Q1 2019 | $9,605,000 | -15.9% | 500,000 | -37.5% | 4.57% | -47.5% |
| Q4 2018 | $11,416,000 | -73.3% | 800,000 | -61.1% | 8.71% | -43.0% |
| Q3 2018 | $42,816,000 | -61.9% | 2,055,500 | -56.7% | 15.27% | -23.7% |
| Q2 2018 | $112,433,000 | +31.5% | 4,750,000 | -18.8% | 20.02% | +43.4% |
| Q1 2018 | $85,469,000 | -21.6% | 5,850,000 | -13.3% | 13.96% | -32.2% |
| Q4 2017 | $109,080,000 | +5.4% | 6,750,000 | -8.8% | 20.59% | +11.0% |
| Q3 2017 | $103,525,000 | +632.8% | 7,405,206 | +362.8% | 18.55% | +369.2% |
| Q2 2017 | $14,128,000 | +334.2% | 1,600,000 | +218.1% | 3.95% | +412.8% |
| Q1 2017 | $3,254,000 | -81.5% | 503,000 | -89.5% | 0.77% | -88.2% |
| Q4 2016 | $17,616,000 | +38.7% | 4,800,000 | +22.8% | 6.55% | +37.3% |
| Q3 2016 | $12,703,000 | +28.6% | 3,908,600 | -8.2% | 4.77% | +0.5% |
| Q2 2016 | $9,880,000 | -28.5% | 4,258,600 | -22.9% | 4.75% | -38.6% |
| Q1 2016 | $13,815,000 | +13.5% | 5,526,172 | +39.4% | 7.73% | +32.7% |
| Q4 2015 | $12,170,000 | +313.5% | 3,964,033 | +131.7% | 5.82% | +241.6% |
| Q3 2015 | $2,943,000 | – | 1,711,067 | – | 1.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |